Home/Pipeline/Borealis

Borealis

Concussion / Mild Traumatic Brain Injury (mTBI) Assessment

Pre-clinicalActive

Key Facts

Indication
Concussion / Mild Traumatic Brain Injury (mTBI) Assessment
Phase
Pre-clinical
Status
Active
Company

About Cerora

Cerora, founded in 2013 and headquartered in Bethlehem, Pennsylvania, is a private diagnostics company targeting the significant unmet need in objective brain injury assessment. Its core technology, the Borealis biosensor platform, integrates multiple data sources within a challenge paradigm to move beyond subjective symptom reporting for conditions like concussion. The company is in the development and regulatory phase, building a team with neurology and engineering expertise to bring its portable diagnostic tool to clinicians.

View full company profile